Welcome to our dedicated page for Skyward Specialty Insurance Group SEC filings (Ticker: SKWD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reserve development tables, reinsurance treaties and segment loss ratios in Skyward Specialty Insurance Group’s (SKWD) filings can overwhelm even seasoned analysts. If you have ever searched for “Skyward Specialty Insurance Group insider trading Form 4 transactions� or wondered how to decode statutory versus GAAP numbers in the 10-K, you know the challenge.
Stock Titan solves that problem. Our AI reads every Skyward Specialty Insurance Group quarterly earnings report 10-Q filing, flags shifts in combined ratios, and produces plain-English takeaways. Need real-time alerts? The platform streams Skyward Specialty Insurance Group Form 4 insider transactions real-time minutes after they hit EDGAR. From 8-K material events explained to a proxy statement executive compensation breakdown, our AI-powered summaries turn hundreds of pages into a concise brief you can act on.
- Quickly scan a Skyward Specialty Insurance Group annual report 10-K simplified to see reserve adequacy and catastrophe exposure.
- Track Skyward Specialty Insurance Group executive stock transactions Form 4 before and after major storms.
- Get instant Skyward Specialty Insurance Group earnings report filing analysis that highlights premium growth by division.
Whether you are understanding Skyward Specialty Insurance Group SEC documents with AI for strategic underwriting insights or verifying solvency ratios, every filing type is covered with up-to-the-minute updates. Skip the technical jargon—our expert layer explains what moves loss ratios, how reinsurance affects capital, and why management’s disclosures matter. Explore Skyward Specialty Insurance Group SEC filings explained simply and make better decisions, faster.
Skyward Specialty Insurance Group reported material insurance reserves and a control weakness while maintaining regulatory capital and recent financing activity. The company held $1.8 billion of reserves for unpaid losses and loss adjustment expenses at December 31, 2024, with a significant portion as IBNR estimated by actuarial methods and subject to estimation uncertainty. The auditor communicated a valuation critical audit matter on reserve estimates and expressed an adverse opinion on internal control over financial reporting. Reinsurance recoverables included concentrations with Everest Reinsurance Co. (18.0%) and eMaxx Captives (16.8%) and reinsurance collateral totaled $337.0 million. Financing actions included a $57.0 million FHLB term loan secured by pledged securities and earlier IPO and follow-on offerings that generated approximately $62.0 million and $62.5 million net proceeds respectively. Statutory measures showed net income of $108.2 million and statutory capital and surplus of $710.6 million for 2024.